news_image.jpg

Elagolix may not be suitable as a contraceptive

08 Nov 2019



Elagolix, used to treat endometriosis pain, suppresses but does not consistently inhibit ovulation and therefore may not be suitable as a contraceptive, according to a study published in The Journal of Endocrinology & Metabolism.

Endocrinology Advisor



Issue 46 - Winter 2019 - Endocrine Disruptors

Latest Newsletter

Issue 46 - Winter 2019 - Endocrine Disruptors

Issue 46 - Winter 2019 - Endocrine Disruptors

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive